phenytoin (n = 58), 10 (4-17) ,ug/ml carbamazepine (n = 37), and 40 (12-68) Ag/ml phenobarbitone (n = 43). The plasma concentrations were higher than 20 ,ug/ml phenytoin, 6 /.Lg/ml carbamazepine and 20 ,tg/ml phenobarbitone in 89%, 84% and 81% 'of the patients, respectively. Therapeutic drug monitoring was not available during five drug regimens. In 64 of the 82 patients high dose antiepileptic drug treatment resulted in an increased or unchanged seizure frequency in 31 patients, a reduction of seizure frequency of less than 75% in 21 patients, and a reduction of more than 75% in 12 patients.
For assessment of clinical characteristics 18 patients who became completely controlled were compared with 64 patients who continued to have seizures and 31 patients with an increased or unchanged seizure frequency.
Results
Most patients had had chronic epilepsy with complex partial seizures for more than 10 years and reported multiple seizure types. Twenty three per cent gave a history of status epilepticus (table 1) . Psychiatric examination was abnormal in 56%, and a suicide attempt was reported by 16%.
The clinical characteristics of patients with and without complete seizure control are compared in table 3. The most striking difference was a markedly lower number of seizures in the 12 months before high dose treatment in the 18 patients who became free of seizures as compared to the 31 patients with an increased or unchanged frequency of seizures (p < 0-0001). The 18 patients who became seizurefree more often had complex partial seizures without automatisms (22%), and curiously, a history of status epilepticus with generalised tonic-clonic seizures (28%). In contrast, four clinical features were found more frequently in the history of the 64 patients whose seizures were not completely controlled. These are: severe depression or paranoid psychotic episodes (33%), a cluster of seizures lasting more than two subsequent days (72%), two or more complex partial seizures per day (61%), and an aura preceding the complex partial seizures in 22% (table 3 ). An improvement of the seizure frequency by more than 75% was noted in one out of 11 patients (9%) with one of these four clinical features, in five out of 25 patients (20%) with two features, in four out of 19 patients (21%) with three features, and in one out of nine patients (11 %) without any of these features. None of the features appeared therefore to exert any marked influence Schmidt 
The results suggest that a careful history will uncover clinical features associated with a successful or unsuccessful response to high dose antiepileptic drug therapy in an epileptic out-patient with chronic complex partial seizures. A low seizure frequency before high dose treatment and lack of ictal automatism are associated with a good seizure prognosis while a high seizure frequency before the high dose treatment, clusters of seizures, a history of more than 1 complex partial seizure per day, an onset of the complex partial seizures with an aura and a history of severe depression or paranoid psychosis suggest a guarded prognosis for complete seizure control.
This series of patients who were referred to a seizure clinic for intractable complex partial seizures shares a number of clinical features consistently associated with poor seizure prognosis such as multiple seizure types, childhood onset, abnormal neurological examination, and a high seizure frequency.2 Previous prognostic data are available from prospective studies of patients which unfortunately did not include drug monitoring or evidence for high dose antiepileptic drug therapy.56
One of the clinical features associated with a good outcome was recognised during the last century by Gowers7 who reported that a low seizure frequency before any treatment generally suggested a good prognosis. Recent evidence from another series of 120 patients with complex partial seizures shows a better seizure control in patients with a total of less than six generalised tonic-clonic seizures as compared to patients with one or more generalised tonic-clonic seizures per month before the treatment.8 In agreement with this study, the existence of rare generalised tonic-clonic seizures does not compromise the outcome in our series. The unexpected relative excess of status epilepticus in patients with excellent prognosis will need further investigation.
The finding that complex partial seizures without automatism do respond better to drug therapy than those with automatism may be related to the recent proposal that complex partial seizures with an initial motionless stare do benefit more from temporal lobe surgery than patients with automatisms.9 If the excellent response to drug therapy or temporal lobe resection has a common pathophysiological basis, a thorough therapeutic reevaluation with a high dose antiepileptic drug therapy may be especially valuable in patients with initial motionless stare before surgery is considered.
The development of clusters and more than one seizure per day -may be -related to the higher frequency of seizures in the group with a poorer outcome and are difficult to evaluate separately in this study. The occurrence of an aura renders the outcome a little less favourable which may be not surprising if an aura is considered a focal seizure element and in adults focal seizures generally carry a poorer treatment prognosis as compared to generalised seizures. ' The comparative efficacy of the four antiepileptic drugs cannot be evaluated as the choice of drugs was not randomised. However, all uncontrolled patients received at least one alternative single drug trial or two drug therapy before the epilepsy was considered to be intractable. ' 2 Thus, the choice of the antiepileptic drug is not considered to effect the conclusions in this study.
Finally, the data suggest that adequate high dose antiepileptic drug therapy may result in seizure control in 22% and in significant reduction of seizure frequency in a further 15% in this group of patients who have been difficult to treat and have been referred to a special clinic. This encouraging result shows that optimum antiepileptic therapy has considerable value even in patients with chronic complex partial seizures. About one third of the patients remain unimproved, however, and are currently being reevaluated for surgical treatment.
